Time: Noon - 1:30 p.m. EST
Dr. Warren Woessner, Schwegman Lundberg & Woessner
Dr. Leslie Fischer, Novartis
Dr. Hans Sauer, BIO
Post-Ariosa, the district courts and the Federal Circuit have increasingly used this decision to justify application of the Mayo/Alice rule to deny the patentability of claims directed to diagnostic methods and products of nature. Apart from the CellzDirect decision, which was characterized as a new method of making freeze/thaw resistant cells, the Court has been resistant to allowing diagnostic claims that arise from the discovery of a naturally occurring correlations.